Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of Nodule Allocation.
- Conditions
- Thyroid GoitreThyroid NoduleThyroid Diseases
- Registration Number
- NCT03128255
- Lead Sponsor
- Jena University Hospital
- Brief Summary
Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- patients with thyroidal nodules,
- euthyroidism
- Uptake >0,5% on Tc-99m-pertechnetate- scintigraphy
Exclusion Criteria
- thyroid medications in the last 6 months
- Iodine exposition in the last 6 months
- thyroid surgery or radioiodine therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Metabolic-sonographic nodule allocation 1 year The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Jena
🇩🇪Jena, Thuringia, Germany
University Hospital Jena🇩🇪Jena, Thuringia, GermanyMartin Freesmeyer, Dr.med.Contact+49 3641 9-329805martin.freesmeyer@med.uni-jena.de
